Literature DB >> 10759427

Proliferative and apoptotic responses in cancers with special reference to oral cancer.

A R Kamer1, L Krebs, S A Hoghooghi, C Liebow.   

Abstract

The study of signal transduction pathways for mechanisms of apoptosis and proliferation has significantly advanced our understanding of human cancer, subsequently leading to more effective treatments. Discoveries of growth factors and oncogenes, especially those that function through phosphorylation on tyrosine residues, have greatly benefited our appreciation of the biology of cancer. The regulation of proliferation and apoptosis through phosphorylation via tyrosine kinases and phosphatases is discussed, as well as the contributions of other systems, such as serine and threonine kinases and phosphatases. Receptors with seven-transmembrane domains, steroid hormones, genes, and "death domains" will also be discussed. This review attempts to compare the regulation of the growth of normal tissues and cancers with an effort to highlight the current knowledge of these factors in the growth regulation of oral/oropharyngeal cancers. Despite the strides made in our understanding of growth regulation in human cancers, the study of oral/oropharyngeal cancer specifically lags behind. More research must be done to further our understanding of oral cancer biology, if we are to develop better, more effective treatment protocols.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10759427     DOI: 10.1177/10454411990100010301

Source DB:  PubMed          Journal:  Crit Rev Oral Biol Med        ISSN: 1045-4411


  2 in total

1.  Apoptosis in primary oral squamous cell carcinomas without lymph node metastases.

Authors:  Zhi Yan; Guomin Wang; Zhiyong Xie; Handong Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

2.  Identification of autophagy-related biomarker and analysis of immune infiltrates in oral carcinoma.

Authors:  Honghai Fu; Dianguo Zhao; Legang Sun; Yumei Huang; Xiangrui Ma
Journal:  J Clin Lab Anal       Date:  2022-04-14       Impact factor: 3.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.